83 related articles for article (PubMed ID: 28629664)
1. Essential elements of personalized medicine.
Burke W; Brown Trinidad S; Press NA
Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
[TBL] [Abstract][Full Text] [Related]
2. Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access.
Fenton SE; VanderWeeler DJ; Rebbeck TR; Chen DL
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433138. PubMed ID: 38781539
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
Fayanju OM; Park KU; Lucci A
Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
[TBL] [Abstract][Full Text] [Related]
4. Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Sutera P; Deek MP; Van der Eecken K; Wyatt AW; Kishan AU; Molitoris JK; Ferris MJ; Siddiqui MM; Rana Z; Mishra MV; Kwok Y; Davicioni E; Spratt DE; Ost P; Feng FY; Tran PT
Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S73-S85. PubMed ID: 35657158
[TBL] [Abstract][Full Text] [Related]
5. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
Samirae L; Krausewitz P; Alajati A; Kristiansen G; Ritter M; Ellinger J
Int J Urol; 2024 May; 31(5):578-580. PubMed ID: 38363018
[No Abstract] [Full Text] [Related]
6. Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.
Ali A; Hoyle A; Baena E; Clarke NW
Curr Opin Urol; 2017 May; 27(3):217-224. PubMed ID: 28212121
[TBL] [Abstract][Full Text] [Related]
7. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
Urabe F
Int J Urol; 2024 May; 31(5):581. PubMed ID: 38469670
[No Abstract] [Full Text] [Related]
8. PAM50 and Beyond: When Will Tissue Transcriptomics Guide Clinical Decision-making?
Haywood SC; Gupta S; Heemers HV
Eur Urol Focus; 2022 Jul; 8(4):916-918. PubMed ID: 36031559
[TBL] [Abstract][Full Text] [Related]
9. [Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer].
Wikström P; Bergh A; Josefsson A; Thysell E; Welén K
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38656744
[TBL] [Abstract][Full Text] [Related]
10. Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.
Tsalatsanis A; Hozo I; Kumar A; Djulbegovic B
PLoS One; 2015; 10(8):e0134800. PubMed ID: 26244571
[TBL] [Abstract][Full Text] [Related]
11. Precision Treatments in Epilepsy.
Demarest S; Brooks-Kayal A
Neurotherapeutics; 2021 Jul; 18(3):1429-1431. PubMed ID: 34704188
[No Abstract] [Full Text] [Related]
12. How glycomic studies can impact on prostate cancer.
Tkac J; Bertok T
Expert Rev Proteomics; 2023; 20(10):189-191. PubMed ID: 37767873
[No Abstract] [Full Text] [Related]
13. Forget lung, breast or prostate cancer: why tumour naming needs to change.
André F; Rassy E; Marabelle A; Michiels S; Besse B
Nature; 2024 Feb; 626(7997):26-29. PubMed ID: 38347121
[No Abstract] [Full Text] [Related]
14. Genetic biomarkers of cancer risk.
Calzone KA
Semin Oncol Nurs; 2012 May; 28(2):122-8. PubMed ID: 22542320
[TBL] [Abstract][Full Text] [Related]
15. Guide to presenting clinical prediction models for use in clinical settings.
Bonnett LJ; Snell KIE; Collins GS; Riley RD
BMJ; 2019 Apr; 365():l737. PubMed ID: 30995987
[No Abstract] [Full Text] [Related]
16. The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
Maurer T; Thomas C; Hadaschik B
J Nucl Med; 2024 Mar; 65(3):430-431. PubMed ID: 38360053
[No Abstract] [Full Text] [Related]
17. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
Palapattu GS
J Urol; 2017 Aug; 198(2):265-266. PubMed ID: 28629664
[No Abstract] [Full Text] [Related]
18. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No.
Punnen S; Parekh DJ
J Urol; 2017 Aug; 198(2):266-267. PubMed ID: 28629663
[No Abstract] [Full Text] [Related]
19. Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.
Nguyen JK; Magi-Galluzzi C
Adv Anat Pathol; 2018 Sep; 25(5):293-303. PubMed ID: 29727322
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]